Playlist
Ashgabat Celebrates the 77th Anniversary of ICCR
09 Apr. 16:19A special event marking the 77th anniversary of the Indian Council for Cultural Relations (ICCR) was held at the Embassy of India in Turkmenistan. The celebration brought together members of the diplomatic community, students, cultural figures, and participants of ICCR programs.
The event began with a presentation video highlighting ICCR’s activities as one of India’s leading institutions in cultural diplomacy. The video showcased international educational programs, cultural initiatives, and opportunities that allow young people to explore India through academic and exchange experiences.
The Ambassador of India to Turkmenistan, Bandaru Wilsonbabu, delivered a speech emphasizing the importance of ICCR in strengthening cultural ties between nations. He noted that the organization will continue to expand its educational, cultural, and short-term exchange programs, offering new opportunities for young people.
The cultural program added a vibrant dimension to the evening. Guests enjoyed yoga performances that combined elements of movement, discipline, and artistic expression. Traditional Indian dances were also performed, while Indian songs were beautifully presented by Turkmen singer Tachnabat Yomudowa, receiving warm applause from the audience.
Participants of ICCR programs also shared their personal experiences, highlighting how studying and visiting India opened new horizons and enriched their understanding of the country’s culture.
The evening concluded with a reception featuring traditional Indian cuisine, creating a warm and welcoming atmosphere for informal общения and networking.
The celebration of ICCR’s 77th anniversary once again demonstrated the strengthening cultural ties between Turkmenistan and India and highlighted the importance of international cooperation in education and culture.
Also read


Simple Vitamin Shows Surprising Results in Pre-Cancerous Blood Conditions, Study Finds
Today in 02:02Daily high-dose supplementation of vitamin C can significantly reduce mortality risks and help prevent severe medical complications in patients with pre-cancerous blood conditions. Researchers from the Van Andel Institute in the United States and Copenhagen University Hospital in Denmark reached this conclusion following a comprehensive three-year follow-up study. The international "EVITA" trial involved volunteers who were administered 1,000 mg of vitamin C daily over the course of a year, while a control group received a placebo.
Although initial hypotheses suggested vitamin C might directly inhibit abnormal cell proliferation, researchers found its primary benefit lay in strengthening the body, reducing systemic inflammation, and lowering rates of anemia, pneumonia, and internal bleeding. Over the three-year observation period, the vitamin C group exhibited a significantly higher survival rate compared to the placebo group. While experts emphasize that these findings remain preliminary and require larger clinical trials before reshaping formal medical treatment protocols, vitamin C continues to show promising potential in supportive patient care.
Also read